Compare LGND & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGND | TRMK |
|---|---|---|
| Founded | 1987 | 1889 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 2.3B |
| IPO Year | 1992 | 1987 |
| Metric | LGND | TRMK |
|---|---|---|
| Price | $193.02 | $40.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $144.71 | $42.67 |
| AVG Volume (30 Days) | 139.7K | ★ 276.0K |
| Earning Date | 08-05-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | N/A | ★ 10.82 |
| EPS | N/A | ★ 3.66 |
| Revenue | $181,488,000.00 | ★ $773,338,000.00 |
| Revenue This Year | $18.41 | $58.57 |
| Revenue Next Year | $18.87 | $4.65 |
| P/E Ratio | ★ N/A | $11.10 |
| Revenue Growth | 53.40 | ★ 55.58 |
| 52 Week Low | $81.74 | $29.77 |
| 52 Week High | $129.90 | $41.34 |
| Indicator | LGND | TRMK |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 64.62 |
| Support Level | $179.65 | $40.36 |
| Resistance Level | $192.44 | $41.22 |
| Average True Range (ATR) | 6.38 | 1.05 |
| MACD | -0.77 | 0.21 |
| Stochastic Oscillator | 48.44 | 92.52 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.